Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer

Tzu-Chieh Yin; Hsiang-Lin Tsai; Ping-Fu Yang; Wei-Chih Su; Cheng-Jen Ma; Ching-Wen Huang; Ming-Yii Huang; Chun-Ming Huang; Jaw-Yuan Wang
April 2017
World Journal of Surgical Oncology;4/11/2017, Vol. 15, p1
Academic Journal
Background: After a low anterior resection, creating a defunctioning stoma is vital for securing the anastomosis in low-lying rectal cancer patients receiving concurrent chemoradiotherapy. Although it decreases the complication and reoperation rates associated with anastomotic leakage, the complications that arise before and after stoma closure should be carefully evaluated and managed. Methods: This study enrolled 95 rectal cancer patients who received neoadjuvant concurrent chemoradiotherapy and low anterior resection with anastomosis of the bowel between July 2010 and November 2012. A defunctioning stoma was created in 63 patients during low anterior resection and in another three patients after anastomotic leakage. Results: The total complication rate from stoma creation to closure was 36.4%. Ileostomy led to greater renal insufficiency than colostomy did and significantly increased the readmission rate (all p < 0.05). The complication rate related to stoma closure was 36.0%. Patients with ileostomy had an increased risk of developing complications (p = 0.017), and early closure of the defunctioning stoma yielded a higher incidence of morbidity (p = 0.006). Multivariate analysis revealed that a time to closure of =109 days was an independent risk factor for developing complications (p = 0.007). Conclusions: The optimal timing of stoma reversal is at least 109 days after stoma construction in rectal cancer patients receiving concurrent chemoradiotherapy and low anterior resection.


Related Articles

  • Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. Lin, Junzhong; Peng, Jianhong; Qdaisat, Aiham; Li, Liren; Chen, Gong; Lu, Zhenhai; Wu, Xiaojun; Gao, Yuanhong; Zeng, Zhifan; Ding, Peirong; Pan, Zhizhong // Journal of Cancer Research & Clinical Oncology;Dec2016, Vol. 142 Issue 12, p2551 

    Purpose: In addition to tumor factors, poor nutritional status before and during anti-tumor treatment might compromise prognosis in several types of cancer. This study was done to determine the impact of weight loss during preoperative chemoradiotherapy (CRT) on the survival outcome of patients...

  • A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance. Cafferty, Fay H.; Sasieni, Peter D.; Duffy, Stephen W. // Statistical Methods in Medical Research;Apr2009, Vol. 18 Issue 2, p163 

    There is evidence that the removal of adenomas, by endoscopy, from the large bowel can prevent the occurrence of colorectal cancer (CRC). However, the reduction in cancer incidence due to endoscopic surveillance is difficult to estimate. Studies of cohorts of adenoma patients typically rely on...

  • Skin Metastases of Rectal Adenocarcinoma: About One Case. Garoui, K.; Zerrouk, D.; Filali, T. // Pan Arab Journal of Oncology;Jun2016, Vol. 9 Issue 2, p56 

    Introduction: Cutaneous metastasis from rectal adenocarcinoma is a rare event, occurring in less than 5%. They appear in an average of 3-4 years after resection of the primary tumor. When present, it usually means the spread of the disease and a poor prognosis. Case report: Women 64 years old....

  • Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010. Smith-Gagen, Julie; Goodwin, George; Tay, Jonathan // Journal of Cancer Research & Clinical Oncology;Jun2014, Vol. 140 Issue 6, p949 

    Objective: This report investigated the impact of radiation therapy among stage II/III rectal cancer patients who were resected for cure and then developed second primary cancer. Methods: The analysis included patients diagnosed with rectal cancer from 1992 to 2010 and who were registered in the...

  • The nutritional impact of diverting stoma-related complications in elderly rectal cancer patients. Kye, Bong-Hyeon; Kim, Hyung-Jin; Kim, Jun-Gi; Cho, Hyeon-Min // International Journal of Colorectal Disease;Oct2013, Vol. 28 Issue 10, p1393 

    Purpose: Diverting stomas following rectal cancer surgery can affect patients' quality of life, and their complications may negatively affect patients' long-term outcomes and quality of life. The purpose of this study is to investigate the relationship between diverting stoma-related...

  • Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Osti, Mattia; Agolli, Linda; Bracci, Stefano; Masoni, Luigi; Valeriani, Maurizio; Falco, Teresa; De Sanctis, Vitaliana; Maurizi Enrici, Riccardo // International Journal of Colorectal Disease;Jul2014, Vol. 29 Issue 7, p835 

    Purpose: The primary end-points were complete pathological response and local control. Secondary end-points were survivals, anal sphincter preservation, and toxicity profile. Methods: Patients with T3/T4 and or N+ rectal cancer ( n = 65) were treated with preoperative concomitant boost...

  • Hemi-levator excision to provide greater sphincter preservation in low rectal cancer. AlAsari, Sami F.; Lim, Daero; Kim, Nam Kyu // International Journal of Colorectal Disease;Dec2013, Vol. 28 Issue 12, p1727 

    The article focuses on the use of a hemi-levator excision technique to a selected subgroup of patients with rectal cancer at the level of the levator ani muscle. The technique utilizes the benefits of a robotic surgical system and unilateral excision of the levator ani and deep part of the...

  • Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Lim, Seok-Byung; Yu, Chang Sik; Kim, Chan Wook; Yoon, Yong Sik; Park, Seong Ho; Kim, Tae Won; Kim, Jong Hoon; Kim, Jin Cheon // International Journal of Colorectal Disease;Dec2013, Vol. 28 Issue 12, p1667 

    Purpose: To identify the indication and prognostic significance of lateral lymph node (LLN) excision in locally advanced rectal cancer patients underwent preoperative chemoradiotherapy. Methods: Included were 67 consecutive patients with suspicious LLN metastasis who underwent chemoradiotherapy...

  • Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades. Wiegering, Armin; Isbert, Christoph; Dietz, Ulrich A.; Kunzmann, Volker; Ackermann, Sabine; Kerscher, Alexander; Maeder, Uwe; Flentje, Michael; Schlegel, Nicolas; Germer, Christoph-Thomas; Klein, Ingo // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    The management of rectal cancer (RC) has substantially changed over the last decades with the implementation of neoadjuvant chemoradiotherapy, adjuvant therapy and improved surgery such as total mesorectal excision (TME). It remains unclear in which way these approaches overall influenced the...

  • Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy? Peng Gao; Yong-xi Song; Jing-xu Sun; Xiao-wan Chen; Ying-ying Xu; Jun-hua Zhao; Xuan-zhang Huang; Hui-mian Xu; Zhen-ning Wang // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background There is no general agreement about whether patients who have already received neoadjuvant chemoradiotherapy need further postoperative chemotherapy based on 5-fluorouracil(5-FU) or 5-FU plus oxaliplatin. Methods Medicare beneficiaries from 1992 to 2008 with Union for International...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics